Interestingly, an in vitro model studying the interaction of RCC cell lines with CAFs elucidated that co-culture of RCC cells with CAFs increases cell proliferation activity as well as the migration potential as compared with serum-free medium controls promoting CAFs as an innovative TME target for future RCC therapies (61). This evidence concerns the gene TBX1 and renal cell adenocarcinoma.